{"id": 5171, "input_str": " To boost safety and effectiveness, some changes could be made to the premarket approval supplement pathway through which some high-risk medical devices are cleared for use, according to a commentary in Annals of Internal Medicine.\n\nAlthough first-generation versions of high-risk devices, such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT", "correct_token_str": ")", "generated_token_str": "),", "generator_index": 0, "correct_logprobs": [-1.536441445350647, -1.1336398124694824, -0.798001766204834], "generated_logprobs": [-1.2777754068374634, -0.42441895604133606, -0.6198554039001465], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}